Highlights
NASDAQ: SPHS       Sophiris Bio
Last Price Today's Change   Day's Range   Trading Volume
0.656   -0.005 (0.76%)  0.64 - 0.70  386,600

Overview

 
Avg Volume (4 weeks):757,894
4 Weeks Range:0.33 - 0.94
4 Weeks Price Volatility (%):
53.44%
52 Weeks Range:0.33 - 1.35
52 Weeks Price Volatility (%):
31.96%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Sophiris Bio Inc is a clinical-stage biopharmaceutical company. It focuses on the development of products for the treatment of urological diseases. The company's product portfolio includes topsalysin (PRX302), for the treatment of lower urinary tract symptoms of benign prostatic hyperplasia (BPH), as well as for the treatment of localized low to intermediate risk prostate cancer. Topsalysin is a genetically modified recombinant protein which is selectively activated by enzymatically active prostate-specific antigen (PSA), which is only present in the prostate, leading to localized cell death and tissue disruption without damage to neighboring tissue and nerves. Geographically all the operations are functioned through the regions of Canada.

  Be the first to like this.
 


 

3414  4674  636  186 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NIO 4.67+0.30 
 TTNP 0.334+0.084 
 SPY 331.95+1.03 
 SNCA 1.60+0.35 
 EEM 46.23+0.26 
 AVP 5.60-0.05 
 AMD 50.93+1.16 
 CHK 0.661-0.029 
 BAC 34.71-0.01 
 GE 11.81-0.03 
Partners & Brokers